FEBS, the Federation of European Biochemical Societies
Founded on 1st January 1964, the Federation of European Biochemical Societies (FEBS) has become one of Europe’s largest organizations in the molecular life sciences. It has over 30,000 members across 39 biochemistry and molecular biology Societies (its ‘Constituent Societies’) in different countries of Europe and regions. As a grass-roots organization, FEBS thereby provides a voice to a large part of the academic research and teaching community in Europe and beyond.
As a charity, FEBS promotes and supports biochemistry, molecular biology, cell biology, molecular biophysics and related research areas through its journals, Congress, Advanced Courses, Fellowships, FEBS Excellence Awards and other initiatives. There is an emphasis in many programmes on scientific exchange and cooperation between scientists working in different countries, and on promotion of the training of early-career scientists.
FEBS Press journals
The publication of high-quality journals by scientists for scientists is one of FEBS’ core objectives, reaching the global scientific community. The FEBS Journal publishes high-quality full-length papers and reviews, with a particular focus on biochemistry, molecular biology, structural biology and cell biology. FEBS Letters is renowned for its speed of publication, and publishes both short reports and full-length research articles, as well as cutting-edge reviews, including those from some of the invited speakers at this Congress in a virtual collection. Both of these journals present annual awards for an outstanding research paper and the recipients are among the plenary lectures at this Congress. FEBS Open Bio is a fully open access journal offering rapid publication of scientifically sound research articles and research protocols. It supports early-career researchers at the Congress through an article prize, and offers speed talk prizes. Also fully open access, Molecular Oncology focuses on high-impact discoveries, approaches and technical advances in basic, clinical and discovery-driven translational cancer research.
For further information about FEBS, visit the FEBS website: www.febs.org
